...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Updated Van Leeuwenhoeck Analyst Report by Marcel Wijma 5/2/2019
Reply New Message
Prev Message Back To Forum Threaded View Next Message

Bardoxolone is their lead compound

The MOA appears to be Nrf2 similiar to Complexa Inc CXA-10

Recent P2 data of improvement in eGFR resulted in a run to over 3 Billion US

I think its possible that given different MOA’s that 208 could be highly synergistic as well as a comparable .

I have owned all 3 Companies and am long RVX and Complexa ( private Co)

 

 

 

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply